Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial Presented at NKF Spring Clinical Meetings
- Friday, April 14, 2023, 7:12
- PR Newswire
- Add a comment
AUSTIN, Texas, April 14, 2023 /PRNewswire/ — The main results of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial, a National Heart, Lung, and Blood Institute (NHLBI) sponsored trial were presented. Although the…
About the Author
admin has written 20972 stories on this site.